About Aurigon
Aurigon is a company based in Munchen (Germany) founded in 2000. Aurigon offers products and services including Safety Assessment and Bioanalysis.
- Headquarter Munchen, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aurigon Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$967.09 K (USD), Grant
Jun 01, 2019
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurigon
Aurigon offers a comprehensive portfolio of products and services, including Safety Assessment and Bioanalysis.
Safety assessment services are provided to evaluate risks in drug development, supporting both in-vivo and in-vitro studies.
Bioanalysis services are offered to analyze biological samples in drug research, aiding in pharmacodynamics and related processes.
Funding Insights of Aurigon
Investors in Aurigon
Aurigon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Aurigon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aurigon
Investment portfolio details for Aurigon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aurigon
Detailed financials for Aurigon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurigon Comparisons
Peer comparison for Aurigon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aurigon
Detailed competitors of Aurigon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurigon
Complete news archive for Aurigon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurigon
Aurigon was founded in 2000 and raised its 1st funding round 19 years after it was founded.
Aurigon is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Aurigon was founded in 2000 and is based in Munich, Germany. Services are offered in the pharmaceutical sector, focusing on advisory and experimental support for drug research and testing. Early-stage product development is assisted through in-vivo and in-vitro studies, safety assessments, bioanalysis, pharmacodynamics, and bioassays. Strategy consulting and GxP training are also provided to clients.
Aurigon offers Safety Assessment and Bioanalysis.
Aurigon has 1 investor. Key investors include European Union.